Literature DB >> 7586273

Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model.

R Waksman1, K A Robinson, I R Crocker, C Wang, M B Gravanis, G D Cipolla, R A Hillstead, S B King.   

Abstract

BACKGROUND: Neointima formation contributing to recurrent stenosis remains a major limitation of percutaneous transluminal angioplasty. Endovascular low-dose gamma-irradiation has been shown to reduce intimal thickening (hyperplasia) after balloon overstretch injury in pig coronary arteries, a model of restenosis. The objective of this study was to determine whether the use of a beta-emitting radioisotope for this application would have similar effects and to examine the dose-response relations with this approach. METHODS AND
RESULTS: Normal domestic pigs underwent balloon overstretch injury in the left anterior descending and left circumflex and coronary arteries. A flexible catheter was introduced by random assignment into one of these arteries and was afterloaded with a 2.5-cm ribbon of encapsulated 90Strontium/90Yttrium sources (90Sr/Y, a pure beta-emitter). It was left in place for a period of time sufficient to deliver one of four doses: 7, 14, 28, or 56 Gy, to a depth of 2 mm. Animals were killed 14 days after balloon injury, the coronary vasculature was pressure-perfusion fixed, and histomorphometric analysis of arterial cross sections was performed. All arteries treated with radiation demonstrated significantly decreased neointima formation compared with control arteries. The ratio of intimal area to medial fracture length was inversely correlated with increasing radiation dose: control (no radiation), 0.47; 7 Gy, 0.34; 14 Gy, 0.20; 28 Gy, 0.08; and 56 Gy, 0.02 (r = -.78, P < .000001). Scanning electron microscopy demonstrated a confluent layer of endothelium-like cells both in control and in 14 Gy-irradiated arteries. There was neither evidence of significant necrosis nor excess fibrosis in the media, adventitia, or perivascular space of the coronary arteries or adjacent myocardium in the irradiated groups. Furthermore, the exposure to the staff and the total body exposure to the pig with the beta source was a small fraction of the dose previously measured and calculated with 192Ir, a gamma-emitting radioisotope.
CONCLUSIONS: Administration of endovascular beta-radiation to the site of coronary arterial overstretch balloon injury in pigs with 90Sr/Y is technically feasible and safe. Radiation doses between 7 and 56 Gy showed evidence of inhibition of neointima formation. A dose-response relation was demonstrated, but no further inhibitory effect was seen beyond 28 Gy. These data suggest that intracoronary beta-irradiation is practical and feasible and may aid in preventing clinical restenosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586273     DOI: 10.1161/01.cir.92.10.3025

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  15 in total

Review 1.  Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.

Authors:  Marco Zimarino; Giulia Renda; Raffaele De Caterina
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Intravascular radiation for restenosis prevention: could it be the holy grail?

Authors:  S B King
Journal:  Heart       Date:  1996-08       Impact factor: 5.994

Review 3.  Intracoronary brachytherapy in the Cath Lab. Physics dosimetry, technology and safety considerations.

Authors:  R Waksman
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

4.  Intraarterial beta irradiation to reduce restenosis after PTCA. Experimental and clinical experience.

Authors:  V Verin; Y Popowski
Journal:  Herz       Date:  1998-09       Impact factor: 1.443

Review 5.  [Intravascular irradiation in the combined therapy and prevention of restenosis. Overview].

Authors:  D Baumgart; U Quast; R Erbel
Journal:  Herz       Date:  1997-12       Impact factor: 1.443

6.  Early time course of neointima formation and vascular remodelling following percutaneous coronary intervention and vascular brachytherapy of in-stent restenotic lesions as assessed by intravascular ultrasound analysis.

Authors:  A Zimmermann; B Pöllinger; J Rieber; A König; I Erhard; F Krötz; H-Y Sohn; R Kantlehner; W Haimerl; E Dühmke; M Leibig; K Theisen; V Klauss; T M Schiele
Journal:  Z Kardiol       Date:  2005-04

7.  Irradiation inhibits vascular anastomotic stenosis in a canine model.

Authors:  Takeshi Saito; Atsushi Iguchi; Koichi Tabayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-09-24

8.  From basic biology to randomized clinical trial: the Beta Radiation for Arteriovenous Graft Outflow Stenosis (BRAVO II).

Authors:  Prabir Roy-Chaudhury; Perry Arnold; Jeff Seigel; Sanjay Misra
Journal:  Semin Dial       Date:  2012-10-16       Impact factor: 3.455

9.  Human coronary morphology after beta radiation brachytherapy of in-stent restenosis.

Authors:  P H Grewe; T Deneke; C Hanefeld; K-M Müller
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

10.  Verification and uniformity control of doses for Sr/Y intravascular brachytherapy sources using radiochromic film dosimetry.

Authors:  Bayram Demir; Asm Sabbir Ahmed; Erhan Babalik; Mustafa Demir; Tevfik Gürmen
Journal:  J Med Phys       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.